A decade of biocatalysis at glaxo wellcome

Biocatalysis in the Pharmaceutical and Biotechnology Industries

Volumn , Issue , 2006, Pages 53-102

  Mahmoudian, Mahmoud ^a  

^a ROHM AND HAAS COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886021365     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (134)

1. McKinsey & Company, Biotechnology in chemical industry, The McKinsey Quarterly, 2002.
2. Van Arnum, F., White biotechnology: the chemical industry’s next challenge, Focus, 2003; fine chemicals/biopharmaceuticals, Chemical Market Reporter, 263: i24 pFR6-1, 2003.
3. Tamburini, B., Perboni, A., Rossi, T., et al., Preparation of 10-(1-hydroxyethyl)-11-oxo-1-azatricyclo[ 7.2.0.0.3,8]undec-2-ene-2-carboxylic acid derivatives as antibacterials, Eur. Patent Appl., 0416953, 1991.
4. Stead, P., Marley, H., Mahmoudian, M., et al., Efficient procedures for the large-scale preparation of (+)-(1S, 2S)-trans-2-methoxycyclohexanol, a key chiral intermediate in the synthesis of tricyclic β-lactam antibiotics, Tetrahedron Asymmetry, 7(8), 2247-2250, 1996.
5. Laumen, K., Breitgoff, D., Seemayer, R., et al., Enantiomerically pure cyclohexanols and cyclohexane-1,2-diol derivatives; chiral auxiliaries and substitutes for (-)-8-phenylmenthol: a facile enzymatic route, J. Chem. Soc. Chem. Commun., 148-150, 1989.
6. Basavaiah, D. and Krishna, P.R., Pig liver powder as biocatalyst: enantioselective synthesis of trans-2-alkoxycyclohexan-1-ols. Tetrahedron, 50, 10521-10530, 1994.
7. Honig, H. and Seufer-Wasserthal, P., A general method for the separation of enantiomeric trans-2-substituted cyclohexanols, Synthesis, 1137-1140, 1990.
8. Halpern, B. and Westley, J.W., Chemical resolution of secondary alcohols, Aust. J. Chem., 19, 1533-1538, 1966.
9. Averett, D.R., Koszalka, G.W., Fyfe, J.A., et al., 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus, Antimicrob. Agents Chemother., 35, 851-857, 1991.
10. Lambe, C.U., Averett, D.R., Paff, M.T., et al., 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies, Cancer Res., 55, 3352-3356, 1995.
11. Krenitsky, T.A., Averett, D.R., Moorman, A.R., et al., Method of treating T-Cell lymphoblastic leukaemia with ara-G nucleoside derivatives, U.S. Patent Appl., 5492897, 1996.
12. Moorman, A.R., Chamberlain, S.D., Jones, L.A., et al., 5'-ester prodrugs of the varicella-zoster antiviral agent, 6-methoxypurine arabinoside, Antiviral Chem. Chemother., 3, 141-146, 1992.
13. Eaddy, J., Glaxo Wellcome R&D, USA, unpublished work, 1997.
14. Mahmoudian, M., Eaddy, J., and Dawson M.J., Enzymatic acylation of 506U78: a powerful new anti-leukaemic agent, Biotechnol. Appl. Biochem., 29, 229-233, 1999.
15. Gregson, M., Ayres, B.E., Ewan, G.B., et al., 2,6-Diaminopurine derivatives, PCT Int. Appl., WO 9417090, 1994.
16. Isono, Y. and Hoshino, M., Nucleoside oxidase and assay method utilizing same, U.S. Patent Appl., 5156955, 1992.
17. Isono, Y., Sudo, T., and Hoshino, M., Purification and reaction of a new enzyme, nucleoside oxidase, Agric. Biol. Chem., 53, 1663-1669, 1989.
18. Isono, Y., Sudo, T., and Hoshino, M., Properties of a new enzyme, nucleoside oxidase, from Pseudomonas maltophilia LB-84, Agric. Biol. Chem., 53, 1671-1677, 1989.
19. Misaki, H., Ikuta, S., and Matsunia, K., Nucleoside oxidase and process for making same, and process and kit for using same, U.S. Patent Appl., 4385112, 1983.
20. Mahmoudian, M., Rudd, B.A.M., Cox, B., et al., A versatile procedure for the generation of nucleoside 5'-carboxylic acids using nucleoside oxidase, Tetrahedron, 54, 8171-8182, 1998.
21. Gallo, R.C., Sarin, P.S., Gelman, E.P., et al., Isolation of a human T-cell leukaemia virus in AIDS, Science, 220, 865-867, 1983.
22. Fauchi, A.S., Masur, H., Gelman, E.P., et al., NIH conference: the AIDS update, Ann. Intern. Med., 102, 800-813, 1985.
23. Coates, J.A.V., Cammack, N., Jenkinson, H.J., et al., (-)-2'-Deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus Type 1 and Type 2 replication in vitro, Antimicrob. Agents Chemother., 36, 733-739, 1992.
24. Coates, J.A.V., Cammack, N., Jenkinson, H.J., et al., The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH189) both inhibit human immunodeficiency virus replication in vitro, Antimicrob. Agents Chemother., 36, 202-205, 1992.
25. Cameron, J.M., Collis, P., Daniel, M., et al., Lamivudine, Drugs of the Future, 18, 319-323, 1993.
26. Francis, C.E., Hunter, A., Berney, J.J., et al., In vitro myelotoxicity studies with 3TCy: 8th International conference on AIDS and 3rd STD world congress (Amsterdam), Abs. no. PuA. 6027, 1992.
27. Storer, R., Clemens, I.R., Lamont, B., et al., The resolution and absolute stereochemistry of the enantiomers of cis-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (BCH189): equipotent anti-HIV agents, Nucleosides Nucleotides, 12, 225-236, 1993.
28. Mahmoudian, M., Baines, B.S., Drake, C.S., et al., Enzymatic production of optically pure 3TCy (Lamivudine): a potent anti-HIV agent. Enzyme Microb. Technol., 15, 749-755, 1993.
29. Hammer-Jespersen, K., Nucleoside metabolism, in Metabolism of nucleotides, nucleosides, and nucleobases in microorganisms, Munch-Petersen, A., Ed., Academic Press, London, 1983, pp. 203-258.
30. Cousins, R.P.C., Mahmoudian, M., and Youds, P.M., Enzymatic resolution of oxathiolane intermediates: an alternative approach to the anti-viral agent lamivudine (3TCy), Tetrahedron Asymmetry, 6, 393-396, 1995.
31. Mahmoudian, M. and Dawson, M.J., Chemoenzymatic production of the antiviral agent Epivir, in Biotechnology of antibiotics, 2nd Ed., Strohl, W.R., Ed., Marcel Dekker Inc., New York, 1997, pp. 753-777.
32. Daluge, S.M., Therapeutic nucleosides, Eur. Patent Appl., 0434450, 1991.
33. Daluge, S.M., Good, S.S., Faletto, M.B., et al., 1592U89 a novel carbocyclic nucleoside analogue with potent selective anti-HIV activity, Antimicrob. Agents Chemother., 41, 1082-1093, 1997.
34. Evans, C.T. and Roberts, S.M., Chiral azabicycloheptanone and a process for their preparation, Eur. Patent Appl., 0424 064 B1, 1991.
35. Evans, C.T., Roberts, S.M., Shoberu, K.A., et al., Potential use of carbocyclic nucleosides for the treatment of AIDS: chemoenzymatic synthesis of the enantiomers of carbovir, J. Chem. Soc. Perkin Trans., 1, 589-592, 1992.
36. Mahmoudian, M., Lowdon, A., Jones, M.F., et al., A practical enzymatic procedure for the resolution of N-substituted 2-azabicyclo[2.2.1]hept-en-3-one. Tetrahedron Asymmetry, 10, 1201-1206, 1999.
37. Novozyme: Savinase 6T, Lipolase 100T, Novo Nordisk enzyme data sheet, 1996.
38. Dawson, M.J., Mahmoudian, M., and Wallis, C., Process for the enantioselective hydrolysis of N-derivatised lactam, Int. Appl. No. PCT/EP98/05291, 1999.
39. Von Itzstein, M., Wu, W.Y., Kok, G.B., et al., Rational design of potent sialidase-based inhibitors of influenza virus replication, Nature, 363, 418-423, 1993.
40. Schauer, R., Chemistry metabolism and biological function of sialic acids, Adv. Carbohydr. Chem. Biochem., 40, 131-234, 1982.
41. De Ninno, M.P., The synthesis and glycosidation of N-acetyl-D-neuraminic acid, Synthesis, 8, 583-593, 1991.
42. Juneja, L.R., Koketsu, M., Nishimoto, K., et al., Large-scale preparation of sialic acid from chalaza and egg-yolk membrane, Carbohydr. Res., 214, 179-186, 1991.
43. McGuire, E.J. and Binkley, S.B., The structure and chemistry of colominic acid, Biochemistry, 3, 247-251, 1964.
44. Uchida, Y., Tsukada, Y., and Sugimori, T., Improved microbial production of colominic acid, a homopolymer of N-acetyl-D-neuraminic acid, Agric. Biol. Chem., 37, 2105-2110, 1973.
45. Marugane-Shoyu, K.K., Preparation of colominic acid, Jap. Patent Appl. 144989, 1989.
46. Spivak, C.T. and Roseman, S., Preparation of N-acetyl-D-mannosamine (2-acetamido-2-deoxy-Dmannose) and D-mannosamine hydrochloride (2-amino-2-deoxy-D-mannose), J. Am. Chem. Soc., 81, 2403-2404, 1959.
47. Kragl, U., Gygax, D., Ghisalba, O., et al., Enzymatic two-step synthesis of N-acetyl-D-neuraminic acid in the enzyme membrane reactor, Angew Chem. Int. Ed. Engl., 30, 827-828, 1991.
48. Auge, C., David, S., and Gautheron, C., Synthesis with immobilized enzyme of the most important sialic acid, Tetrahedron Lett., 25, 4663-4664, 1984.
49. Bednarski, M.D., Chenault, H.K., Simon, E.S., et al., Membrane-enclosed enzymatic catalysis (MEEC): a useful, practical new method for the manipulation of enzymes in organic synthesis, J. Am. Chem. Soc., 109, 1283-1285, 1987.
50. Kim, M.J., Hennen, W.J., Sweers, H.M., et al., Enzymes in carbohydrate synthesis: N-acetyl-Dneuraminic acid aldolase catalyzed reactions and preparations of N-acetyl-2-deoxy-D-neuraminic acid derivatives, J. Am. Chem. Soc., 110, 6481-6486, 1988.
51. Tsukada, Y. and Ohta, Y., Process for producing N-acetyl-D-neuraminic acid, Eur. Patent Appl. 0578825A1, 1992.
52. Dawson, M.J., Noble, D., and Mahmoudian, M., Process for the preparation of N-acetyl-Dneuraminic acid, PCT W0 9429476, 1994.
53. Mahmoudian, M., Noble, D., Drake, C.S., et al., An efficient process for production of Nacetylneuraminic acid using N-acetylneuraminic acid aldolase, Enzyme Microb. Technol., 20, 393-400, 1997.
54. Starkey, I.D., Mahmoudian, M., Noble, D., et al., Synthesis and influenza virus sialidase inhibitory activity of the 5-desacetoamido analogue of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid (GG167), Tetrahedron Lett., 36, 299-302, 1995.
55. Woods, J.M., Bethell, R.C., Coates, J.A.V., et al., 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro, Antimicrob. Agents Chemother., 37, 1473-1479, 1993.
56. Cermak, R.C. and Vince, R., (±)-4Β-Amino-2α,3α-dihydroxy-1β-cyclopentanemethanol hydrochloride: carbocyclic ribofuranosylamine for the synthesis of carbocyclic nucleosides, Tetrahedron Lett., 22, 2331-2332, 1981.
57. Marquez, V.E. and Lim, M., Carbocyclic nucleosides, Med. Res. Rev., 6, 1-40, 1986.
58. Borthwick, A.D., Butt, S., Biggadike, K., et al., Synthesis and enzymatic resolution of carbocyclic 2'-ara-fluoro-guanosine: a potent new anti-herpetic agent, J. Chem. Soc. Chem. Commun., pp. 656-658, 1988.
59. Vince, R. and Brownell, J., Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-)-enantiomer, Biochem. Biophys. Res. Commun., 168, 912-916, 1990.
60. Balzarini, J., Baumgartner, H., Bodenteich, M., et al., Synthesis and anti-viral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine, J. Med. Chem., 32, 1861-1865, 1989.
61. Balzarini, J., Metabolism and mechanism of anti-retroviral action of purine and pyrimidine derivatives, Pharm. World Sci., 16, 113-126, 1994.
62. Mahmoudian, M., Baines, B.S., Dawson, M.J., et al., Resolution of 4-amino-cyclopentanecarboxylic acid methyl esters using hydrolytic enzymes, Enzyme Microb. Technol., 14, 911-916, 1992.
63. Krenitsky, T.A., Koszalka, G.W., Tuttle, J.V., et al., An enzymatic synthesis of purine D-arabinonucleosides, Carbohydrate Res., 97, 139-146, 1981.
64. Herdewijn, P., Balzarini, J., de Clercq, E.A., et al., Resolution of aristeromycin enantiomers, J. Med. Chem., 28, 1385-1386, 1985.
65. Secrist, J.A., Montgomery, J.A., Shealy Y.F., et al., Resolution of racemic carbocyclic analogues of purine nucleosides through the action of adenosine deaminase: antiviral activity of the carbocyclic 2'-deoxyguanosine enantiomers, J. Med. Chem., 30, 746-749, 1987.
66. Hoong, L.K., Strange, L.E., Liotta, D.C., et al., Enzyme-mediated enantioselective preparation of pure enantiomers of the anti-viral agent 2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds, J. Org. Chem., 57, 5563-5565, 1992.
67. Cameron, J.M., New anti-herpes drugs in development, Rev. Med. Virol., 3, 225-236, 1993.
68. Boehme, R.E., Bereford, A., Hart, G.J., et al., GR95168X (chiral carbocyclic BVdU) is highly effective against simian Varicella virus infections of African green monkeys, Antiviral Res., 23, 97-98, 1994.
69. Sicsic, S., Ikbal, M., and Le Goffic, F., Chemoenzymatic approach to carbocyclic analogues of ribonucleotides and nicotinamide ribose, Tetrahedron Lett., 28, 1887-1888, 1987.
70. Csuk, R. and Doerr, P., Bioanalytical transformations: the 4-acetamido-cyclopent-2-ene carboxylate route revisited; synthesis of (+)-and (-)-aristeromycin, Tetrahedron, 51, 5789-5798, 1995.
71. Borthwick, A.D., Crame, A.J., Mahmoudian, M., et al., A short, convergent synthesis of two chiral anti-viral agents (+)-carbocyclic 2'-deoxy-5-[(E)-2-bromovinyl]uridine and (+)-carbocyclic 2'-deoxyguanosine, Tetrahedron Lett., 36, 6929-6932, 1995.
72. Archelas, A. and Morin, C., Biohydroxylation of a 2-azabicyclo[2.2.1]heptane, Tetrahedron Lett., 25, 1277-1278, 1984.
73. Dawson, M.J., Mahmoudian, M., Rudd, B.A.M., et al., Biosynthesis and biotransformation in the preparation of nucleoside analogues, in Chiral Europe, 1996, pp. 35-38.
74. White, E.L., Parker, W.B., Macy, L.J., et al., Comparison of the effect of carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases, Biochem. Biophys. Res. Commun., 161, 393-398, 1989.
75. Carter, S.G., Kessler, J.A., and Rankin, C.D., Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro, Antimicrob. Agents Chemother., 34, 1297-1300, 1990.
76. Exall, A.M., Jones, M.F., Mo, C.L., et al., Synthesis of (-)-aristeromycin and X-ray structure of (-)-carbovir, J. Chem. Soc. Perkin Trans., 1, 2467-2477, 1991.
77. Pun, K.T., Baines, B.S., and Lawrence, G.C., Isolation, immobilization and use of adenosine deaminase in the synthesis of (-)-carbovir, a purine nucleoside analogue, 5th European congress on biotechnology, Copenhagen, Abs. no. TUP 111, 1990, p. 292.
78. Mahmoudian, M., Top 400 prescription drugs, MedAd News, 3-20, Eastman Chemical Company, USA, unpublished work. 2003.
79. Adamo, M.F.A., Aggarwal, V.K., and Sage, M.A., Epoxidation of alkenes by amine catalyst precursors: implication of aminium ion and radical cation intermediates, J. Am. Chem. Soc., 122, 8317-8318, 2000.
80. Nieuwenhuijzen, J.W., Grimbergen, R.F.P., Koopman, C., et al., The role of nucleation inhibition in optical resolutions with families of resolving agents, Angew. Chem. Int. Ed., 41, 4281-4286, 2002.
81. Henderson, K.W., Kerr, W.J., and Moir, J.H., Enantioselective deprotonation reactions using a novel homochiral magnesium amide base, Chem. Commun., 479-480, 2000.
82. Balint, G., Egri, M., and Czugler, J., Resolution of 1-phenylethylamine by its acidic derivatives, Tetrahedron Asymmetry, 12, 1511-1518, 2001.
83. Varies, T.R., Wynberg, H., van Echten, E., et al., The family approach to the resolution of racemates, Angew. Chem. Int. Ed., 37, 2349-2354, 1998.
84. Messina, F., Botta, M., Corelli, M.P., et al., Stereoselective synthesis of aryl-2-benzofuranmethanamines and aryl-1H-indole-2-methanamines through palladium-mediated annulation of chiral arylpropargylamines, Tetrahedron Asymmetry, 11, 1681-1685, 2000.
85. Luna, A., Alfonso, I., and Gotor, V., Biocatalytic approaches toward the synthesis of both enantiomers of trans-cyclopentane-1,2-diamine, Org. Lett., 4, 3627-3629, 2002.
86. Takayama, S., Lee, S.T., Hung, S.C., et al., Designing enzymatic resolution of amines, Chem. Commun., 127-128, 1999.
87. Gutman, A.L., Meyer, E., Kalerin, E., et al., Enzymatic resolution of racemic amines in continuous reactor in organic solvents, Biotechnol. Bioeng., 40, 760-767, 1992.
88. Jaeger, K., Liebeton, K., Zonta, A., et al., Biotechnological application of Pseudomonas aeruginosa lipase: efficient kinetic resolution of amines and alcohols, Appl. Microbiol. Biotechnol., 46, 99-105, 1996.
89. Stirling, D.I., The use of aminotransferases for the production of chiral amino acids and amines, in Chirality in Industry, Collins, A.N., et al., Eds., Wiley, New York, 1992, pp. 209-222.
90. Matcham, G., Bhatia, M., Lang, W., et al., Enzyme and reaction engineering in biocatalysis: synthesis of (S)-methoxyisopropylamine, Chimia, 53, 584-589, 1999.
91. Shin, J.S., Kim, B.G., Liese, A., et al., Kinetic resolution of chiral amines using enzyme membrane reactors, Biotechnol. Bioeng., 73, 179-187, 2001.
92. Shin, J.S. and Kim, B.G., Comparison of the v-transaminase from different microorganisms and application to production of chiral amines, Biosci. Biotechnol. Biochem., 65, 1782-1788, 2001.
93. Takaaki, Y., Hiroshi, T., and Takeo Y., Production of optically active α-methylbenzylamine, Jap. Patent Appl. 4234993A, 1991.
94. Uematsu, N., Fujii, A., Hashiguchi, S., et al., Asymmetric transfer hydrogenation of imines, J. Am. Chem. Soc., 118, 4916-4917, 1996.
95. Okuda, J., Verch, S., Sturmer, R., et al., Chiral complexes of titanium containing a linked amido cyclopentadienyl ligand: synthesis, structure, and asymmetric imine hydrogenation catalysis, J. Organomet. Chem., 605, 55-67, 2000.
96. Kainz, S., Brinkmann, A., Leitner, W., et al., Iridium-catalyzed enantioselective hydrogenation of imines in supercritical carbon dioxide, J. Am. Chem. Soc., 121, 6421-6429, 1999.
97. Hieber, G. and Ditrich, K., Introducing ChiPros biocatalytic production of chiral intermediates on a commercial scale, Chimia Oggi, 19, 16-20, 2001.
98. Reetz, M.T. and Schimossek, K., Lipase-catalyzed dynamic kinetic resolution of chiral amines: use of palladium as the racemisation catalyst, Chimia, 50, 668-689, 1996.
99. Choi, Y.K., Kim, M.J., Ahn, Y., et al., Lipase palladium-catalyzed asymmetric transformations of ketoximes to optically active amines, Org. Lett., 3, 4099-4101, 2001.
100. Pamies, O., Ell, A.H., Samec, J.S.M., et al., An efficient and mild ruthenium-catalyzed racemisation of amines: application to the synthesis of enantiomerically pure amines, Tetrahedron Lett., 43, 4699-4702, 2002.
101. Hirrlinger, B. and Stolz, A., Formation of a chiral hydroxamic acid with an amidase from Rhodococcus erythropolis MP50 and subsequent chemical Losen rearrangement to a chiral amine, Appl. Environ. Microbiol., 63, 3390-3393, 1997.
102. Chapman, D.T., Crout, D.H.G., Mahmoudian, M., et al., Enantiomerically pure amines by a new method: biotransformation of oxalamic esters using the lipase from Candida antarctica, Chem. Commun., 2415-2416, 1996.
103. Enright, A. and Mahmoudian, M., Deracemisation of chiral amines and amino acids, Glaxo Wellcome R&D, UK, unpublished work, 2001.
104. Alexeeva, M., Enright, A., Mahmoudian, M., et al., Deracemisation of amines, PCT Int. Appl. WO 030-80855, 2003.
105. Alexeeva, M., Enright, A., Mahmoudian, M., et al., Deracemisation of α-methylbenzylamine using an enzyme obtained by in vivo evolution, Angew. Chem. Int. Ed., 41, 3177-3180, 2002.
106. Uppenberg, J., Hansen, M.T., Patkar, S., et al., The sequence, crystal structure determination and refinement of two crystal forms of lipase B from Candida antarctica, Structure, 2, 293-308, 1994.
107. Chapman, D.T., Mahmoudian, M., and Crout, D.H.G., Glaxo Wellcome R&D, UK, unpublished work, 1995.
108. Hafner, E.W. and Wellner, D., Demonstration of imino acids as products of the reactions catalyzed by D-and L-amino acid oxidases, Proc. Natl. Acad. Sci. USA, 68, 987-991, 1971.
109. Huh, J.W., Yokoigawa, K., Soda, K.J., et al., Synthesis of L-proline from the racemate by coupling of enzymic enantiospecific oxidation and chemical non-enantiospecific reduction, J. Ferment. Bioeng., 74, 189-190, 1992.
110. Huh, J.W., Yokoigawa, K., Soda, K.J., et al., Total conversion of racemic pipecolic acid into the L-enantiomer by a combination of enantiospecific oxidation with D-amino acid oxidase and reduction with sodium borohydride, Biosci. Biotech. Biochem., 56, 2081-2082, 1992.
111. Quay, S. and Massey, V., Effect of pH on the interaction of benzoate and D-amino acid oxidase, Biochemistry, 16, 3348-3354, 1977.
112. Pollegioni, L., Buto, S., Tischer, W., et al., Characterization of D-amino acid oxidase from Trigonopsis variabilis, Biochem. Mol. Biol. Int., 31, 709-717, 1993.
113. Pantaleone, D.P., Geller, A.M., and Taylor, P.P., Purification and characterization of an L-amino acid deaminase used to prepare unnatural amino acids, J. Mol. Cat. B Enzyme, 11, 795-803, 2001.
114. Braun, M., Kim, J.M., and Schmid, R.D., Purification and some properties of an extracellular Lamino acid oxidase from Cellulomonas cellulans AM8 isolated from soil, Appl. Microbiol. Biotechnol., 37, 594-598, 1992.
115. Truong, M., Lecornue, F., and Fadel, A., First synthesis of (1S,2S)-and (1R,2R)-1-amino-2-isopropylcyclobutanecarboxylic acids by asymmetric Strecker reaction from 2-substituted cyclobutanones, Tetrahedron Asymmetry, 14, 1063-1072, 2003.
116. Johnstone, R.A.W., Wilby, A.H., and Entwistle, I.D., Heterogeneous catalytic transfer hydrogenation and its relation to other methods for reduction of organic compounds, Chem. Rev., 85, 129-170, 1985.
117. Hutchins, R.O., Learn, K., Nazer, B., et al., Amine boranes as selective reducing and hydroborating agents: a review, Org. Prep. Proc. Int., 16, 335-372, 1984.
118. Frebort, I., Matsushita, K., and Adachi, O., Involvement of multiple copper/topa containing and flavin containing amine oxidases and NADP aldehyde dehydrogenases in amine degradation by filamentous fungi, J. Ferment. Bioeng., 84, 200-212, 1997.
119. Silverman, R.B., Cesarone, J.M., and Liu, X., Stereoselective ring opening of 1-phenylcyclopropylamine catalyzed by monoamine oxidase, J. Am. Chem. Soc., 115, 4955-4961, 1993.
120. Schilling, B. and Lerch, K., Amine oxidases from Aspergillus niger: identification of a novel flavindependent enzyme, Biochim. Biophys. Acta., 1243, 529-539, 1995.
121. Schilling, B. and Lerch, K., Cloning, sequencing and heterologous expression of the monoamine oxidase gene from Aspergillus niger, Mol. Gen. Genet., 247, 430-438, 1995.
122. Sablin, S.O., Yankovskaya, V., Bernard, S., et al., Isolation and characterization of an evolutionary precursor of human monoamine oxidases A and B, Eur. J. Biochem., 253, 270-279, 1998.
123. Korbel, G.A., Lalic, G., and Shair, M.D., Reaction microarrays: a method for rapidly determining the enantiomeric excess of thousands of samples, J. Am. Chem. Soc., 123, 361-362, 2001.
124. Badalassi, F., Wahler, D., Klein, G., et al., A versatile periodate-coupled fluorogenic assay for hydrolytic enzymes, Angew. Chem. Int. Ed., 39, 4067-4070, 2000.
125. Reetz, M.T. and Sostmann S., 2,15-Dihydroxyhexahelicene (HELIXOL): synthesis and use as an enantioselective fluorescent sensor, Tetrahedron, 57, 2515-2520, 2001.
126. Reetz, M.T., Becker, M.H., Klein, H.W., et al., A method for high-throughput screening of enantioselective catalysts, Angew. Chem. Int. Ed., 38, 1758-1759, 1999.
127. Reetz, M.T., Kühling, K.M., Deege, A., et al., Super high throughput screening of enantioselective catalysts by using capillary array electrophoresis, Angew. Chem. Int. Ed., 39, 3891-3893, 2000.
128. Ding, K., Ishii, A., and Mikami, K., Super high-throughput screening of chiral ligands and activators: asymmetric activation of chiral diol zinc catalysts by chiral nitrogen activators for the enantioselective addition of diethylzinc to aldehydes, Angew. Chem. Int. Ed., 38, 497-501, 1999.
129. Taylor, S.J. and Morken, J.P., Thermographic selection of effective catalysts from an encoded polymer-bound library, Science, 280, 267-270, 1998.
130. Reetz, M.T., Becker, M.H., Kühling, K.M., et al., Time-resolved IR-thermographic detection and screening of enantioselectivity in catalytic reactions, Angew. Chem. Int. Ed., 37, 2647-2649, 1998.
131. Reetz, M.T., Becker, M.H., Liebl, M., et al., IR-thermographic screening of thermoneutral or endothermic transformations: the ring closing olefin metathesis reaction, Angew. Chem. Int. Ed., 39, 1236-1238, 2000.
132. Millot, N., Borman, P., Mahmoudian, M., et al., Rapid determination of enantiomeric excess using infrared thermography, Org. Process R&D, 6, 463-470, 2002.
133. Corey, E.J. and Helal, C.J., Reduction of carbonyl compounds with chiral oxazaborolidine catalysts: a new paradigm for enantioselective catalysis and a powerful new synthetic method, Angew. Chem. Int. Ed., 37, 1986-2012, 1998.
134. Anderson, E.M., Larsson, K.M., and Kirk, O., One biocatalyst many applications: the use of Candida antarctica B lipase in organic synthesis, Biocatal. Biotrans., 16, 181-185, 1998.